Evidence map›Paper›PMID 39738020›Full record

ArticleNature communications2024

Functional anatomy of zinc finger antiviral protein complexes.

Jennifer A Bohn, Jennifer L Meagher, Matthew A Takata, Daniel Gonçalves-Carneiro, Zoe C Yeoh, Melanie D Ohi, Janet L Smith, Paul D Bieniasz

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. A minimal complex of KHNYN and zinc-finger antiviral protein binds and degrades single-stranded RNA.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jennifer A BohnLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.
Jennifer L MeagherLife Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Matthew A TakataLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.
Daniel Gonçalves-CarneiroLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA.
Zoe C YeohLife Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
Melanie D OhiLife Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0003-1750-4793
Janet L SmithLife Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-0664-9228
Paul D BieniaszLaboratory of Retrovirology, The Rockefeller University, New York, NY, 10065, USA. pbieniasz@rockefeller.edu.ORCID 0000-0002-2368-3719

Funding

Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
Cellular RNA-binding Zinc Finger Proteins in Viral Infection: Understanding the Rules of EngagementF32AI160904 · NIAID · ROCKEFELLER UNIVERSITY · PI BOHN, JENNIFER · 2021 to 2022
$120k
Howard Hughes Medical Institute (HHMI)NIAID NIH HHS U54 AI170660U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) F32AI160904
6 · The paper itself

Abstract

ZAP is an antiviral protein that binds to and depletes viral RNA, which is often distinguished from vertebrate host RNA by its elevated CpG content. Two ZAP cofactors, TRIM25 and KHNYN, have activities that are poorly understood. Here, we show that functional interactions between ZAP, TRIM25 and KHNYN involve multiple domains of each protein, and that the ability of TRIM25 to multimerize via its RING domain augments ZAP activity and specificity. We show that KHNYN is an active nuclease that acts in a partly redundant manner with its homolog N4BP1. The ZAP N-terminal RNA binding domain constitutes a minimal core that is essential for antiviral complex activity, and we present a crystal structure of this domain that reveals contacts with the functionally required KHNYN C-terminal domain. These contacts are remote from the ZAP CpG binding site and would not interfere with RNA binding. Based on our dissection of ZAP, TRIM25 and KHNYN functional anatomy, we could design artificial chimeric antiviral proteins that reconstitute the antiviral function of the intact authentic proteins, but in the absence of protein domains that are otherwise required for activity. Together, these results suggest a model for the RNA recognition and action of ZAP-containing antiviral protein complexes.

Indexed as

RNA-Binding ProteinsTranscription FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesZinc FingersBinding SitesCrystallography, X-RayEndonucleasesHEK293 CellsHumansModels, MolecularProtein BindingProtein DomainsRepressor ProteinsRNA, ViralEndonucleasesRepressor ProteinsRNA-Binding ProteinsRNA, ViralTranscription FactorsTRIM25 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesYLPM1 protein, humanZC3HAV1 protein, human

Identifiers

PMID39738020
PMCPMC11685948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.